AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $20,000 | -47.4% | 31,275 | -44.4% | 0.00% | – |
Q2 2019 | $38,000 | -78.8% | 56,200 | -74.3% | 0.00% | – |
Q1 2019 | $179,000 | -60.7% | 218,789 | -23.1% | 0.00% | -100.0% |
Q4 2018 | $455,000 | +810.0% | 284,645 | +717.8% | 0.00% | – |
Q1 2015 | $50,000 | -93.0% | 34,805 | -95.9% | 0.00% | -100.0% |
Q4 2014 | $711,000 | -22.7% | 845,751 | +2.0% | 0.00% | 0.0% |
Q3 2014 | $920,000 | -51.2% | 829,210 | -19.5% | 0.00% | -66.7% |
Q2 2014 | $1,886,000 | +14.0% | 1,030,292 | -6.9% | 0.00% | +50.0% |
Q1 2014 | $1,655,000 | -2.8% | 1,106,682 | +19.6% | 0.00% | 0.0% |
Q4 2013 | $1,702,000 | +1.1% | 925,254 | +13.7% | 0.00% | -33.3% |
Q3 2013 | $1,684,000 | +69.2% | 813,645 | +104.4% | 0.00% | +50.0% |
Q2 2013 | $995,000 | – | 398,047 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |